Renaissance Capital logo

ACRS News

Dermatology biotech Sienna Biopharmaceuticals sets terms for $65 million IPO

Sienna Biopharmaceuticals, a clinical-stage biotech developing topical therapies for dermatological conditions, announced terms for its IPO on Monday. The Westlake Village, CA-based company plans to raise $65 million by offering 4.3 million shares at a...read more

US IPO Weekly Recap: Cut the offer price for positive returns

Continuing the recent trend, four out of five deals priced below the range. This week, five companies raised $765 million, pricing an average of 19% below their proposed midpoints. All four deals that priced below traded up, popping 10% on...read more

Aclaris Therapeutics prices IPO at $11, below the range

Aclaris Therapeutics, which is developing a proprietary hydrogen peroxide treatment for common skin lesions, raised $55 million by offering 5 million shares at $11, below the range of $14 to $16. Aclaris Therapeutics plans to list on the Nasdaq under the symbol...read more

Week ahead: Fourth quarter kicks off with 11 IPOs set for the week of October 5

As many as 11 companies could go public this week, including the year's largest IPO (Digicel) and the fastest-growing company (Pure Storage). Both have proposed market caps of more than $3.5 billion, while six others target valuations of $300 million or...read more